Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Parkinson's Patients May Be at Higher Risk for Malnutrition

    Higher Vitamin C and E Intake Linked to Lower Parkinson’s Risk

    In an observational study using diet questionnaires, researchers linked higher consumption of vitamin C and E to a lower risk of Parkinson’s disease.
    Learn more
  • Female researcher in lab with tool.

    What We Fund: $19.7 Million in New Grants for Parkinson's Research

    The Michael J. Fox Foundation announces 44 new grants in critical areas of Parkinson’s research including new treatments, earlier diagnosis and understanding of disease mechanisms.
    Learn more
  • Gloved hand holding test tube with alpha-synuclein on label

    Trial Begins for Potential Parkinson's Drug after $1.4 Million Grant from Michael J. Fox Foundation

    A trial in the United Kingdom is testing a drug against alpha-synuclein in people with Parkinson’s disease after our Foundation invested nearly $1.4 million.
    Learn more
  • Taking someone's blood in clinic

    Research Roundup: Recruiting Trials Testing Innovative Ways to Treat or Stop Parkinson’s

    Researchers are exploring innovative ways to treat Parkinson’s and slow or stop its progression. Here, we share a roundup of a few clinical trials — some with MJFF funding — recruiting volunteers…
    Learn more
  • Second Parkinson’s Vaccine Reports Positive Safety Results

    Positive News for COVID-19 Vaccines: What Does It Mean for the Parkinson’s Community?

    Trials of two COVID-19 vaccines recently reported the vaccines are highly effective in preventing infection. Read more about this news and what it means for people with Parkinson’s.
    Learn more
  • Do not use- Two researchers in a lab

    Trial Testing Dyskinesia Drug Moves Forward with Support from Global Parkinson’s Organizations

    The Michael J. Fox Foundation is collaborating with Parkinson’s UK to fund a Phase II clinical trial of a new drug called NLX-112 with biopharma company Neurolixis.
    Learn more
  • Default content image

    Foundation Confers Edmond J. Safra Humanitarian Award to Lily Safra and Honors Distinguished Scientists with 2020 Major Research Prizes

    The Foundation honored two researchers for their groundbreaking work in Parkinson's disease and dystonia research and announced a new humanitarian award on November 17, 2020.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.